77 related articles for article (PubMed ID: 9311620)
41. Pharmacokinetics of a novel histone deacetylase inhibitor, apicidin, in rats.
Shin BS; Chang HS; Park EH; Yoon CH; Kim HY; Kim J; Ryu JK; Zee OP; Lee KC; Cao D; Yoo SD
Biopharm Drug Dispos; 2006 Mar; 27(2):69-75. PubMed ID: 16299816
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
Bae SK; Lee SJ; Lee JY; Lee Y; Lee I; Kim SG; Lee MG
Int J Pharm; 2004 May; 275(1-2):227-38. PubMed ID: 15081153
[TBL] [Abstract][Full Text] [Related]
43. Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids.
Salem OI; Frotscher M; Scherer C; Neugebauer A; Biemel K; Streiber M; Maas R; Hartmann RW
J Med Chem; 2006 Jan; 49(2):748-59. PubMed ID: 16420060
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the relationship between serum and milk residue disposition of ceftriaxone in lactating ewes.
Goudah A; Shin HC; Shim JH; Abd El-Aty AM
J Vet Pharmacol Ther; 2006 Aug; 29(4):307-12. PubMed ID: 16846468
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours.
Bae SK; Lee SJ; Kim JW; Kim YH; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 Mar; 26(2):77-83. PubMed ID: 15617135
[TBL] [Abstract][Full Text] [Related]
46. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR.
Bramson HN; Hermann D; Batchelor KW; Lee FW; James MK; Frye SV
J Pharmacol Exp Ther; 1997 Sep; 282(3):1496-502. PubMed ID: 9316864
[TBL] [Abstract][Full Text] [Related]
47. Kinetics of distribution of di-propranolol in various organs and discrete brain areas of the rat.
Bianchetti G; Elghozi JL; Gomeni R; Meyer P; Morselli PL
J Pharmacol Exp Ther; 1980 Sep; 214(3):682-7. PubMed ID: 7400970
[TBL] [Abstract][Full Text] [Related]
48. [Penetration of ampicillin and oxacillin into the tissues of rats with aseptic inflammation].
Agapitova IV; Bobrov VI; Trubnikov VI; Iakovlev VP
Antibiotiki; 1984 May; 29(5):370-3. PubMed ID: 6742809
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics, tissue distribution, excretion, and metabolism of a new cardioprotective agent 10-O-dimethylaminoethylginkgolide B in rats.
Wang DL; Peng DY; Liu XD; Zhang X; Chen WD; Liang Y; Wang XT; Xie T; Xie L; Wang GJ
J Asian Nat Prod Res; 2012; 14(1):27-38. PubMed ID: 22263591
[TBL] [Abstract][Full Text] [Related]
50. Physiological pharmacokinetic modelling.
Balant LP; Gex-Fabry M
Xenobiotica; 1990 Nov; 20(11):1241-57. PubMed ID: 2275217
[TBL] [Abstract][Full Text] [Related]
51. Disposition of bisantrene in humans and rabbits: evidence for intravascular deposition of drug as a cause of phlebitis.
Powis G; Kovach JS
Cancer Res; 1983 Feb; 43(2):925-9. PubMed ID: 6848203
[TBL] [Abstract][Full Text] [Related]
52. Hormonal effects of Z-350, possessing steroid 5alpha-reductase inhibitory and alpha1-adrenoceptor antagonistic actions, in the rat.
Fukuda Y; Fukuta Y; Higashino R; Yoshida K; Ogishima M; Takei M; Kurimoto T
Jpn J Pharmacol; 2001 Jul; 86(3):323-8. PubMed ID: 11488433
[TBL] [Abstract][Full Text] [Related]
53. Comparison of two and three compartment models of phencyclidine in man.
Domino SE; Domino LE; Domino EF
Subst Alcohol Actions Misuse; 1982; 3(4):205-11. PubMed ID: 7167862
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of trimethoprim in the rat.
Tu YH; Allen LV; Fiorica VM; Albers DD
J Pharm Sci; 1989 Jul; 78(7):556-60. PubMed ID: 2778654
[TBL] [Abstract][Full Text] [Related]
55. (E)-4-(2-[[3-(indol-5-yl)-1-oxo-2-butenyl]amino]phenoxy)butyric acid derivatives: a new class of steroid 5 alpha-reductase inhibitors in the rat prostate. 1.
Kumazawa T; Takami H; Kishibayashi N; Ishii A; Nagahara Y; Hirayama N; Obase H
J Med Chem; 1995 Jul; 38(15):2887-92. PubMed ID: 7636849
[TBL] [Abstract][Full Text] [Related]
56. [Distribution of intravenously injected enzymes of heterologous, homologous and autologous origin. Distribution and transport of cell enzymes within the extracellular space. III (author's transl)].
Friedel R; Bode R; Trautschold I
J Clin Chem Clin Biochem; 1976 Mar; 14(3):129-36. PubMed ID: 932646
[TBL] [Abstract][Full Text] [Related]
57. [Kidney and drugs - urinary lithiasis. Pharmacokinetic glossary].
Balant L
Rev Med Suisse Romande; 1980 Nov; 100(11):949-56. PubMed ID: 7466067
[No Abstract] [Full Text] [Related]
58. Disposition of 6-amino-5-(N-methylformylamino)-1,3-dimethyluracil, one of the primary metabolites of caffeine, in the rat.
Bonati M; Bortolotti A; Jiritano L; Latini R; Garattini S
Drug Metab Dispos; 1983; 11(5):509-11. PubMed ID: 6138240
[No Abstract] [Full Text] [Related]
59. Pharmacokinetic studies on ditazole, a novel inhibitor of platelet aggregation.
Marcucci F; Riva R; Gomeni R; Zavattini G; Lacombe PS; Mussini E
J Pharm Sci; 1978 May; 67(5):705-6. PubMed ID: 25334
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of 3-[Bis(2-hydroxyethyl)amino]acetophenone-(4,5- diphenyloxazol-2-yl)hydrazone (ZIMET 98/69) in mice.
Amlacher R; Ulbricht H
Acta Virol; 1984 Sep; 28(5):445. PubMed ID: 6151361
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
